Published by ChinaMNC · Quyang

China's Health Sector Priorities Signal Opportunities for Foreign Founders

A national health conference in Beijing outlines China's health development direction for the 15th Five-Year Plan period. For foreign entrepreneurs, the emphasis on health industry growth, medical innovation, and preventive care may open doors for company registration in relevant sectors.

What the Health Conference Means for Your China Company Registration

On October 12–13, 2026, China held its National Health Conference in Beijing, where top leaders outlined the direction for the health sector during the “15th Five-Year Plan” period (2026–2030). While the meeting focused on domestic health strategy, it carries practical implications for foreign founders considering company registration in China’s health-related industries.

Key Takeaways for Foreign Founders

• Health industry growth is a priority: The conference emphasized “making the health industry bigger and stronger” (做大做强健康产业) by strengthening basic research and original innovation in health and promoting the transfer of scientific achievements. For foreign founders in medtech, pharmaceuticals, digital health, or wellness, this signals potential policy support and market demand.
• Preventive care and healthy lifestyles: Officials highlighted prevention as the most cost-effective health strategy and called for guiding the public toward healthy habits, supporting fitness and healthy leisure, and strengthening food safety supervision. This could create opportunities in nutrition, fitness tech, food safety compliance, and health management services.
• Integrated healthcare and primary care: The conference stressed optimizing the layout of medical institutions, promoting hierarchical diagnosis and treatment, and improving chronic disease management. Foreign investors in telemedicine, clinic chains, or medical devices may find entry points, though licensing requirements remain stringent.
• Traditional Chinese Medicine (TCM) and integrated medicine: There is a push to improve the mechanism for TCM inheritance and innovation and to strengthen integrated Chinese-Western medicine. Foreign founders with expertise in herbal medicine, TCM products, or integrative care should note the regulatory pathways, which often require local partnerships or specialized approvals.
• Medical insurance and drug procurement reform: The conference reiterated reforms in medical insurance, drug procurement, and payment policies, aiming for “safe fund operation, sound hospital operations, and reasonable patient burden.” For foreign companies in pharmaceuticals or medical devices, understanding China’s centralized procurement and reimbursement landscape is crucial.

What This Means for Company Registration

While the conference does not directly change registration procedures, it reinforces the government’s focus on health-sector development. Foreign founders looking to establish a presence in China’s health industry should consider the following practical steps:

• Entity choice: A wholly foreign-owned enterprise (WFOE) is common for trading and consulting, but if you plan to provide medical services, you may need a Sino-foreign joint venture (JV) with a Chinese partner, as medical institutions often face restrictions on foreign ownership. Manufacturing of medical devices or pharmaceuticals may be allowed under a WFOE but requires specific licenses.
• Registration steps: Begin with name pre-approval, then obtain a business license from the local Administration for Industry and Commerce (now Market Supervision Administration). After that, you’ll need to complete tax registration, open a bank account, and obtain any sector-specific permits.
• Documents: Typically, you’ll need notarized and apostilled incorporation documents from your home country, a feasibility study, and articles of association. For health-related businesses, additional approvals from the National Medical Products Administration (NMPA) or health commissions may be required.
• Capital: China has largely moved to a subscribed capital system, but certain sectors (e.g., medical institutions) may have minimum capital requirements. Consulting with local authorities is advised.
• Tax and compliance: Health companies should be aware of value-added tax (VAT) rates, potential preferential policies for high-tech enterprises, and strict advertising and anti-corruption rules in the medical field.

Sector-Specific Licensing

Foreign founders should note that health-related businesses often require special licenses. For example:

• Medical devices: Class I devices require filing; Class II and III require registration with NMPA, which may involve clinical trials.
• Pharmaceuticals: Drug registration and manufacturing licenses are mandatory, and foreign companies typically need a local agent or JV.
• Healthcare services: Operating a clinic or hospital requires approval from the health commission, and foreign ownership may be capped.
• Food and health supplements: Health food products need registration or filing with the State Administration for Market Regulation (SAMR).

Opportunities in Prevention and Wellness

The conference’s emphasis on prevention and healthy lifestyles may lower barriers for non-medical wellness businesses. For instance, fitness centers, health food stores, and wellness apps may face fewer regulatory hurdles than clinical services. However, food safety and advertising laws remain strict, so compliance is essential.

Conclusion

China’s health sector priorities for the 15th Five-Year Plan period indicate a growing market for innovative health products and services. Foreign founders should carefully assess their business scope, choose the right entity structure, and prepare for sector-specific licensing. While the registration process is standardized, health-related businesses require extra diligence.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

For assistance with registering and operating a company in China, foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535.